Insulin infographics The cost-saving impact of Recombinant Insulin Solutions Realizing economic returns through improved productivity Explore the infographic below to see how the improved process performance achieved with Recombinant Insulin in cell culture, can translate into impressive cost savings for mAb production at both small and large production scales. Download
“Enhancing cell-based vaccine production with new animal-free recombinant proteins”. This is the title of our presentation at The World Vaccine Congress, the world’s leading vaccine event, in Washington, D.C., from April 22 to 24. Our Senior Global Product Manager, Marie-Louise Lunn, Ph.D, will give the presentation on Wednesday, April 23,
Karina Sinding is Corporate Vice President in Product Supply in Novo Nordisk. She has been a member of the Novo Nordisk Pharmatech Board of Directors since 2025 . Ms. Sinding joined Novo Nordisk in 2004 as an Industrial PhD in Research & Development. In 2009, she moved to CMC Development,
Sofie Mørck Jarl is Senior Vice President of Finance and Business Support in Novo Nordisk. Since 2025, she has been a member of the Novo Nordisk Pharmatech Board of Directors. Ms. Jarl joined Novo Nordisk in 2007 and has since held key roles in Business Finance, Corporate Strategy and NNE.
Our purpose – enabling better medicines, enabling better lives has for years centred around our commitment to bring forward pharmaceutical materials that enable our customers to produce better medicines. In 2024, we marked our 75th anniversary, an important milestone in our company’s history. What started as a small chemistry factory
Novo Nordisk Pharmatech’s Recombinant Insulin is a high-purity, animal-free insulin supplement that enhances cell growth and increases protein yields.
Explore the infographic below to discover how Recombinant Insulin can result in up to a 1.7-fold increase in mAb production in CHO-S and CHO-K1 cells. Download the infographic in PDF format using the link at the bottom.
Explore here a renowned, fully animal-free media supplement, frequently utilized for cell culture of CHO, HEK 293, and insect cell lines for the production of monoclonal antibodies, viral vaccines, as well as stem cells and viral vectors.
Join us at Biologics Manufacturing Asia, the continent’s #1 bioprocessing event, on March 12-13 in Singapore. It´s the place to discuss biologic innovations that enhance efficiency and productivity. At booth #5 we’ll showcase Recombinant Insulin and our new enzyme TrypsiNNex®, sharing information about how the products can enhance the safety
In this webinar, the expert speakers will illustrate how both Recombinant Insulin and TrypsiNNex® significantly enhance the safety and efficiency of upstream biomanufacturing processes, thereby enhancing the overall efficiency of therapeutic biologics production.
Københavnsvej 216
4600 Køge,
Denmark
+45 5667 1000
[email protected]
CVR-no. 13246149
